Navigation Links
Effect of tumor necrosis factor a inhibitors on heart failure risk in RA Patients
Date:2/27/2008

A chronic autoimmune disease, rheumatoid arthritis (RA) is characterized by persistent inflammation of the synovial membrane and progressive joint destruction. Beyond loss of mobility, sufferers face a high risk of heart failure. An inflammatory cytokine known for contributing to the development of RA, tumor necrosis factor a (TNFa) has also been implicated in cardiovascular disorders. Inhibition of TNFa has opened promising new treatment options for RA patients. Anti-TNF drugs such as infliximab, etanercept, and adalimumab have been shown to not only diminish signs and symptoms of the disease, but also prevent joint damage. However, in cardiac trials, TNFa inhibitors have shown no more positive effects on heart failure risk -- and sometimes less -- than placebo.

Does TNFa inhibition prevent heart failure in RA patients -- or promote it? That's the critical question Dr. Joachim Listing and a team of specialists with the German Rheumatism Research Centre in Berlin set out to answer. Featured in the March 2008 issue of Arthritis & Rheumatism (http://www.interscience.wiley.com/journal/arthritis), their study indicates that anti-TNF therapy does a patients heart more good than harm, when it successfully reduces the inflammatory toll of RA.

To clearly assess the role of TNFa inhibitors in heart failure risk, the researchers analyzed a 3-year span of disease activity and cardiovascular incidents in 4,248 RA patients enrolled in an ongoing Germany-wide study of biologic therapy. At the time of enrollment, 2,757 of the subjects had started treatment with an anti-TNF drug -- infliximab, etanercept, or adalimumab -- and 1,491 had started a new disease-modifying antirheumatic drug (DMARD). Within the study period, several hundred of the patients were also treated with glucocorticoids, nonsteroidal anti-inflammatory drugs (NSAIDs), or COX-2 inhibitors. Over 78 percent of the p
'/>"/>

Contact: Amy Molnar
amolnar@wiley.com
Wiley-Blackwell
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Hormone replacement therapy appears to have no effect on risk and severity of rheumatoid arthritis
2. Colgate Announces 11% Dividend Increase Effective 2nd Quarter 2008
3. Cause of effectiveness discovered for a cirrhosis treatment useful in 40 percent of patients
4. Effective Healthy Eating and Physical Activity Initiatives Can Reduce Health Disparities
5. Prime Therapeutics Introduces Efficiency Program to Help Employers Understand How to Most Effectively Spend Pharmacy Dollars
6. UC study: New devices less effective in thwarting brain aneurysm recurrence
7. Guidelines for evaluation of psychological side-effects of brain injury
8. Researchers explore the antidepressant effects of ketamine
9. Warning: Expert at UH adds obesity to side effects of lead exposure
10. In Combination With FOLFOX4, the Effect of Erbitux and Avastin On Survival Rates Will Drive Prescription Decisions in the Treatment of Stage III Colon Cancer
11. Building an Effective Sales Force to Serve the U.S. Hospital Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Even with years of experience under his belt, Kirk ... growth, participating in two recent events for his State Farm ... networking event with the leaders of State Farm and thousands ... and greatest in insurance news and products for his clients. ... (Stacy, Anthony, Reina and Jacob) as exhibitors at the recent ...
(Date:11/21/2014)... TX (PRWEB) November 21, 2014 ... facility at 7am today. The new facility is located ... open 24-7. , “We are pleased to join ... highest quality emergency medical care here,” said Dr. Siddiqi, ... , To celebrate the opening, First Choice ...
(Date:11/21/2014)... HealthDay Reporter THURSDAY, Nov. 20, 2014 ... of a still-beating heart has the potential to improve the ... new study. Heart patients who received the gel implant ... hundreds of feet farther during a six-minute walk test, said ... cardiovascular division at Washington University School of Medicine and a ...
(Date:11/21/2014)... 20, 2014 (HealthDay News) -- Kidney donation is one ... another. And now a new study finds that former donors ... benefiting from policies that give them priority on the transplant ... of the 16,900 kidney transplants that took place in the ... the study researchers. At the time of donation, ...
(Date:11/18/2014)... Hawthorne cosmetic dentist , Dr. Yashari, is now ... of Americans over the age of 35 are missing a ... are missing not just one but all of their natural ... offers a look, feel, and function that closely resembles that ... consultation that allows patients to learn more about their options. ...
Breaking Medicine News(10 mins):Health News:Kirk Martin Insurance Agency Goes Local and National with State Farm 2Health News:First Choice Emergency Room Opens New Facility in Friendswood, Texas 2Health News:Gel Implant Might Help Fight Heart Failure 2Health News:Gel Implant Might Help Fight Heart Failure 3Health News:Study Supports Giving Kidney Donors Priority When They Need a Kidney 2Health News:Hawthorne Dentist, Dr. Yashari, is Now Making Dental Implants More Affordable for Patients 2
... With seedlings and shoots still poking their leafy tops ... published research of Brown University biologist Alison DeLong without musing ... spring in spring. DeLong,s paper, published in advance online ... insights into the intricate network of proteins that controls plant ...
... 18, 2011 Illicit drug overdose deaths declined dramatically ... facility located in Vancouver, Canada, according to the findings ... Lancet. In the first peer-reviewed ... on overdose mortality, researchers observed a 35% reduction in ...
... EDITORS: Photo available at http://today.uci.edu/news/2011/04/nr_ptips_110421.php Irvine, Calif., ... will use a $3.2 million National Institutes of ... at lessening the anxiety and pain children feel ... professor and chair of anesthesiology & perioperative care, ...
... and working memory may result from an improved ability ... rhythm. This rhythm is thought to "turn down the ... value of meditation may be helping the brain deal ... (MGH), Harvard Medical School and the Massachusetts Institute of ...
... high school athlete drops dead, the rare but fatal ... reasons that remain a mystery to scientists, some young ... an unusual heart arrhythmia. With over-exertion, their hearts stop ... screening for the hard-to-detect syndrome has been prohibitively expensive. ...
... Pediatric Dermatology reveals that routine, long-term use of topical ... any significant, negative side effects. Parental phobia of TCS is ... commonest fear is that TCS use will "thin the skin." ... including pharmacists. Led by Gayle Fischer, MBBS, FACD, of The ...
Cached Medicine News:Health News:In time for spring, biologist illuminates how seedlings regulate growth 2Health News:Deaths from drug overdose decline 35 percent after the opening of supervised injection site 2Health News:UCI anesthesiologist to lead study on alleviating surgical anxiety, pain in children 2Health News:Meditation may help the brain 'turn down the volume' on distractions 2Health News:Meditation may help the brain 'turn down the volume' on distractions 3Health News:Standing up for athletes at risk 2
(Date:11/21/2014)... GABLES, Fla. , Nov. 20, 2014   ... to become the first U.S. commercial producer of Molybdenum-99 ... a contract with INVAP to design its ... Fla. Mo-99 is the parent isotope of ... medicine procedures worldwide. In 2012, Congress passed legislation making ...
(Date:11/18/2014)... LAWRENCE, Mass. , Nov. 18, 2014 /PRNewswire/ ... NXTM ), a leading manufacturer of innovative ... its new  Streamline® Express dialyzer for the ... blood tubing set, which is designed to reduce ... and to reduce the number of touch point ...
(Date:11/18/2014)... Investor-Edge has initiated coverage on the following equities: ... GERN ), Tekmira Pharmaceuticals Corporation (NASDAQ: ... and XOMA Corporation (NASDAQ: XOMA ). Free research ... . The US markets on Monday, November 17, ... Industrial Average finished at 17,647.75, up 0.07% and the NASDAQ ...
Breaking Medicine Technology:Coqui RadioPharmaceuticals Inks Deal With INVAP 2NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set 2Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 2Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 3Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 4Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 5
... 2011 MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) ... featured in one oral presentation and four poster presentations at ... (AAN) in Honolulu, Hawaii April 9-16, 2011. A ... abstracts can be accessed at the AAN website at ...
... Inc. (Nasdaq: MYL ) today announced that its ... U.S. Food and Drug Administration (FDA) for its Abbreviated New ... mg and 400 mg, the generic version of Pfizer,s Neurontin ... shingles. Gabapentin Capsules had U.S. sales of ...
Cached Medicine Technology:MAP Pharmaceuticals to Present Data on LEVADEX™ at the 63rd Annual Meeting of the American Academy of Neurology 2MAP Pharmaceuticals to Present Data on LEVADEX™ at the 63rd Annual Meeting of the American Academy of Neurology 3MAP Pharmaceuticals to Present Data on LEVADEX™ at the 63rd Annual Meeting of the American Academy of Neurology 4
IDS Rapid One, a microbial identification system....
IDS Rapid NF Plus, a microbial identification system....
Versatrek 240 is versatile as four tests can be performed on one platform such as blood culture, sterile body fluids, mycobacteria and mycobacteria susceptibility testing. This model comes equipped w...
BD Phoenix is an automated microbiology system used for identification and susceptibility testing....
Medicine Products: